Speech-Language Pathologists in Desloge, MO Accepting Medicare

6 Speech-Language Pathologists found. Showing 1 - 6

Stephanie Catherine Hughes, M.A., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 801 Brim St, Desloge, MO 63601 Phone: 573-431-0223

Mrs. Kathryn Marie Mcdowell, MA,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 801 Brim St, Desloge, MO 63601 Phone: 573-431-0223    Fax: 573-431-0251

Hannah Marie Jackson, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 801 Brim St, Desloge, MO 63601 Phone: 573-431-0223

Mrs. Kelley Suzanne Bumgardaner, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 801 Brim St, Desloge, MO 63601 Phone: 573-431-0223    Fax: 573-431-0251

Mrs. Nancy Diana Smith, M.A. Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 210 S Harding St, Desloge, MO 63601 Phone: 573-701-2476

Tessa Dunivan Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 801 Brim St, Desloge, MO 63601 Phone: 573-431-0223

News Archive

Phase 2 study of ziresovir for treating hospitalized RSV infected infants achieves significant progress

Ark Biosciences, a biotech company developing proprietary therapeutics for viral infection and respiratory diseases, announced today the significant progress in its phase 2 proof-of-concept study of ziresovir in the treatment of hospitalized RSV infected infants.

Component derived from turmeric essential oil exhibits neuroprotective effects

Researchers from Kumamoto University, Japan have found that a component derived from turmeric essential oil, aromatic turmerone (ar-turmerone), and its derivatives act directly on dopaminergic nerves to create a neuroprotective effect on tissue cultures of a Parkinson's disease model.

Experts develop low-cost method to combat deadly form of air pollution

People could soon be using their smartphones to combat a deadly form of air pollution, thanks to a potentially life-saving breakthrough by RMIT University researchers in Melbourne, Australia.

University's blindness therapy comes a step closer following landmark licensing deal with US firm

Hundreds of thousands of people worldwide, who have a disease that can lead to blindness, could have their sight restored after The University of Manchester entered into a technology license with Seattle-based company Acucela Inc.

Drug-eluting stents effective for diabetic patients

Results of a multicenter study in Asia, demonstrating that drug-eluting stents are effective with a low rate of complications in diabetic patients, will be presented at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).

Read more Medical News

› Verified 2 days ago